Definitive Healthcare Corp.

Greetings and welcome to the Definitive Healthcare fourth quarter and fiscal year 2021 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, David Samuel, General Counsel of Definitive Healthcare. Thank you, David. You may begin.

Good afternoon, and thank you for joining us today to review Definitive Healthcare's fourth quarter 2021 financial results. Joining the call today are Jason Krantz, Definitive Healthcare's founder and CEO, Rick Booth, Definitive Healthcare's CFO, and Robert Musselwhite, Definitive Healthcare's president. During this call, we will make forward-looking statements, including but not limited to statements related to our market and future growth opportunities, the benefits of our healthcare commercial intelligence solutions, our competitive position, customer behaviors, our financial guidance, our planned investments, and the anticipated impact from the COVID-19 pandemic on our business and results of operation, as well as on our clients, the healthcare industry generally, and the macroeconomic environment. Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the risk factor section of our filings with the SEC. Actual results may differ materially from any forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statements included in the earnings release that we just posted to the investor relations portion of our website. Additionally, we will discuss non-GAAP financial performance measures on this conference call. References on this call to profitability are on an adjusted EBITDA basis. Please refer to the tables in our earnings release on the investor relations portion of our website or a reconciliation of these measures to the most directly comparable GAAP financial measures. With that, I'd like to turn the call over to Jason.

Thanks, David. Thank you, everyone, for joining us today for Definitive Healthcare's fourth quarter 2021 earnings call. We ended a transformational year for the company with excellent fourth quarter results that reflect the significant momentum we have across all parts of our business. Our performance demonstrates the significant market opportunity for healthcare commercial intelligence, which we are delivering through our comprehensive SaaS-based platform, our industry-leading data sets, and our proprietary data science-based analytics. We are at the very early stages of a $10 billion and growing market opportunity, and we believe that we're in a great position to generate strong growth and significant profitability for years to come. Let's start today by quickly reviewing our financial results for the fourth quarter and the full year, which reinforce our unique value proposition of high growth, high profitability, and visibility into the future. Starting with the fourth quarter, our total revenue was $46.3 million, which represents 38% year-over-year growth. And our adjusted EBITDA was $13.1 million, which translates into a 28% margin. For the full year, our total revenue was $166.2 million, which represents 40% year-over-year growth. Our adjusted EBITDA was $56.0 million, which translates into a 34% margin. And our unlevered free cash flow was $55.4 million, a 33% margin. We were extremely excited about our performance in the fourth quarter, as we not only surpassed our growth target, but we continued to do so in a highly profitable manner. even with the additional burden of a full quarter of public company expenses and the significant investments that we continue to make in sales, marketing, and product innovation. I'm now going to hand it over to our president, Robert Musselwhite, to talk about some of the drivers of the success, as well as to highlight some key customer wins during the quarter.